Cystoid Macular Edema Clinical Trial
Official title:
Efficacy and Safety of the Treatment of Minocycline for Cystoid Macular Edema
Cystoid macular edema (CME) is one of sight-threatening, immune-related ocular diseases. The efficacy of current treatments for CME (anti-VEGF, glucocorticoids and other agents) are limiting. Minocycline, acting as a broad-spectrum antibiotic, is among tetracycline family and recently, its immunomodulatory and anti-apoptosis function has been replied to several immune diseases and degenerative diseases. This study aims to explore the efficacy and safety of minocycline for CME.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00508040 -
Evaluation of Birdshot Retine Choroidopathy Treatment by Either Steroid or Interferon alpha2a
|
Phase 2 | |
Terminated |
NCT00114062 -
Study to Treat Uveitis Associated Macular Edema
|
Phase 2 | |
Completed |
NCT03025945 -
Prospective Study With Adjunctive Once Daily Topical Nepafenac 0.3% Versus Placebo
|
N/A | |
Completed |
NCT01978015 -
Blood-aqueous Barrier Changes After the Use of Timolol and Prostaglandin Analogues Fixed Combination in Pseudophakic Patients With POAG
|
Phase 4 | |
Recruiting |
NCT05158699 -
Effectiveness of Periocular Drug Injection in CATaract Surgery
|
Phase 3 | |
Withdrawn |
NCT02598869 -
Posterior Subtenon Versus Intravitreal Injection of Triamcinolone Acetonide for Treatment of Uveitic Cystoid Macular Edema
|
Phase 4 | |
Terminated |
NCT04527523 -
Descemet Membrane Endothelial Keratoplasty vs. Descemet's Stripping With Endothelial Keratoplasty vs. Descemet Stripping Only
|
||
Completed |
NCT02294656 -
Acute Pseudophakic Cystoid Macular Edema Treatment Trial: Intravitreal Ranibizumab Versus Triamcinolone Acetonide
|
Phase 1 | |
Withdrawn |
NCT00406172 -
Intravitreal Bevacizumab (Avastin) for Pseudophakic Macular Edema (PME)
|
Phase 3 | |
Not yet recruiting |
NCT04856670 -
Assessing Diabetes Mellitus on Cytokine Analysis and Macular Edema Following FLACS
|
||
Completed |
NCT02609165 -
Nerve Growth Factor Eye Drops Treatment in Patients With Retinitis Pigmentosa and Cystoid Macular Edema
|
Phase 2 | |
Withdrawn |
NCT00438243 -
Pilot Study of the Effect of Topical Bromfenac Ophthalmic Solution 0.09%in Patients With Acute Post-operative Cystoid Macular Edema.
|
Phase 2 | |
Completed |
NCT00464581 -
Lucentis for Treatment of Macular Edema
|
N/A | |
Active, not recruiting |
NCT03465124 -
Evaluation of Central Macular Thickness in Femtosecond Laser-assisted Cataract Surgery
|
N/A | |
Recruiting |
NCT02486484 -
Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection
|
Phase 2 | |
Completed |
NCT00790803 -
Pegaptanib Therapy in Non-Infectious Uveitic Cystoid Macular Edema
|
N/A | |
Recruiting |
NCT04225611 -
Therapeutic Contact Lens Drug Delivery System (TCL-DDS) in Patients With Recurrent Cystoid Macular Edema
|
Phase 1/Phase 2 | |
Completed |
NCT05832996 -
Cool vs Room-temperature Artificial Tears
|
Phase 4 | |
Completed |
NCT05615805 -
The Effect of Ocular Rinse Volume on Surface Irritation After Intravitreal Injections
|
N/A | |
Completed |
NCT00494494 -
Effect of Nepafenac on Post-operative Macular Swelling Following Uncomplicated Cataract Surgery
|
Phase 4 |